To examine whether blocking PLD activity leads to a decrease in the cellular resistance to rapamycin, we treated ADPKD and OX161 cells with a combination of low dose rapamycin and PLD inhibitors. The gene discussed is GPLD1; the disease is autosomal dominant polycystic kidney disease.